Registration Dossier

Diss Factsheets

Administrative data

acute toxicity: inhalation
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
Justification for type of information:
According to REACH Annex XIII Section 8.5 information on acute toxicity will be provided for at least one other route in addition to the oral route. The choice for the second route will depend on the nature of the substance and the likely route of human exposure. The substance is a manufactured as an aqueous solution and supplied as such for use by formulators of personal care products. The most likely route of exposure for consumers is the dermal route. Testing for acute toxicity via the inhalation route is, therefore, not required.

Data source

Materials and methods

Results and discussion

Clinical signs:

Applicant's summary and conclusion